Exscopia
Non-invasive Breath Decoder for Blood Glucose Metering
Health Tech & Life Sciences
Non Active, Jun 2019 ceased to operate
Company Overview
Snapshot
Founded in March 2017 by Michal Badash, Exscopia operated with 1–10 employees. The company ceased operations in June 2019.
Business overview
Exscopia developed a technology for non-invasive, real-time blood glucose metering through breath analysis. The company aimed to provide an absolute measurement in seconds using a small device for personal use, alongside high-performance instruments for clinics capable of analyzing multiple compounds simultaneously. Exscopia focused on the Health Tech & Life Sciences sector, specifically within medical devices and medical treatment, with the goal of simplifying life for diabetics in markets including India, the United States, and Israel.
Log in to access full profile ›Company Intelligence Q&A
- What is Exscopia's primary focus?
- Exscopia focuses on developing a non-invasive breath decoder for blood glucose metering, aiming to provide real-time, sensitive analysis of indicator gases in breath.
- When was Exscopia founded?
- Exscopia was founded in March 2017.
- Who founded Exscopia?
- Exscopia was founded by Michal Badash.
- In which sectors does Exscopia operate?
- Exscopia operates within the Health Tech & Life Sciences sector, specifically focusing on medical devices and medical treatment & therapeutics.
- What is the current status of Exscopia?
- Exscopia is currently non-active, having ceased operations in June 2019.